Enter Your Practice Information





Yes No

Yes No


X
x

Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  • Registration for new subscribers will open in September 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Journal June 2013 (Vol 35, No 6)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Hepatic Encephalopathy: Diagnosis and Treatment by Melissa Salgado , DVM, Yonaira Cortes , DVM, DACVECC

1. Which factor can precipitate development of hepatic encephalopathy (HE) in an animal with a portosystemic shunt?
2. Which laboratory value, if significantly elevated in serum, does not correlate with HE?
3. Which of the following does not support a diagnosis of HE?
4. Lactulose can be an effective treatment for HE because it
5. Which statement is true with regard to antibiotic therapy in the treatment of HE?
6. Which statement regarding nutrition in patients with HE is false?
7. Mannitol decreases intracranial hypertension in HE patients by
8. L-Ornithine-L-aspartate therapy may be effective in treating HE because the drug
9. The Molecular Adsorbent Regenerating Systemdoes not lower plasma levels of
10. The clinical signs of intracranial hypertension associated with type A HE do not include
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More
Subscribe